Robert Stuart to Etoposide
This is a "connection" page, showing publications Robert Stuart has written about Etoposide.
Connection Strength
0.036
-
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trial. Leuk Lymphoma. 2015; 56(9):2569-78.
Score: 0.031
-
Multimodality treatment of advanced head and neck carcinoma. J S C Med Assoc. 1989 Sep; 85(9):409-11.
Score: 0.005